In human glioma tumors and cell lines, SIRT2 deacetylates p65 at lysine 310 and inhibits miR-21 transcription through blocking p65 binding to the miR-21 promoter, suppressing the growth of glioma cells (Figure 4B) [87]. The gene discussed is SIRT2; the disease is central nervous system cancer.